The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the fifth largest territory in the world for pharma manufacturing, a territory with significantly improved capabilities in R&D, medical device and diagnostics manufacturing, and more universities per square mile than anywhere else on the planet. It features interviews with senior executives from the major companies in Puerto Rico and leaders of the country’s most important institutions, updated facts and figures on Puerto Rico’s healthcare and pharma sectors, and an exclusive in-depth cover story, ‘Made in Puerto Rico’.
APAC / IFPMA's Thomas Cueni on the Value of Business Ethics for SMEs during COVID-19
Drawing on the findings of the Business Ethics for APEC SMEs Initiative, Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) outlines the benefits for small and…